Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Epizyme Inc (NASDAQ:EPZM)

12.85
Delayed Data
As of 4:00pm ET
 +0.05 / +0.39%
Today’s Change
9.30
Today|||52-Week Range
20.45
+6.20%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues478.0K0.0010.0M0.00
 
 
 
Depreciation And Amortization400.0K411.0K413.0K406.0K
 
 
 
 
 
 
Operating ExpensesGross Income---411.0K---406.0K
 
 
 
General Expenses35.6M32.6M38.0M37.6M
 
 
 
 
 
Research And Development28.4M24.7M27.3M28.7M
 
 
 
 
 
Total Operating Expenses36.0M33.0M38.5M38.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-35.5M-33.0M-28.5M-38.1M
 
 
 
 
 
Other Expenses31.0K4.0K10.0K-32.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-35.0M-32.5M-28.0M-37.6M
 
 
 
 
 
Net Income-35.0M-32.5M-28.0M-37.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS58.0M58.2M58.4M59.9M
 
 
 
 
 
Shares To Calculate EPS Diluted58.0M58.2M58.4M59.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.60-$0.56-$0.48-$0.63
 
 
 
 
 
EPS Diluted-$0.60-$0.56-$0.48-$0.63